Login / Signup

Germline variation in RASAL2 may predict survival in patients with RAS-activated colorectal cancer.

Christopher WillsKatie WattsTimothy S MaughanDavid J FisherNada A Al-TassanRichard S HoulstonValentina Escott-PriceJeremy P Cheadle
Published in: Genes, chromosomes & cancer (2023)
Our data demonstrate a prognostic role for RASAL2 in patients with MAPK-activated CRCs, with potential as a therapeutic target.
Keyphrases
  • signaling pathway
  • electronic health record
  • oxidative stress
  • big data
  • dna repair
  • pi k akt
  • free survival
  • human health
  • machine learning
  • risk assessment
  • cell proliferation
  • deep learning